Cannabis Medicine Advisory Panel

The goal of the Cannabis Medicine Advisory Panel is to advance research, policy, and best practices for the safe and effective use of medical cannabis. It focuses on fostering collaboration among healthcare professionals, researchers, and policymakers to improve patient access, education, and treatment outcomes.

Aim

The aim of the Enhanced Harm Reduction Working Group is to develop and implement evidence-based strategies to reduce the negative health and social impacts of intravenous drug use, while promoting safe practices, access to treatment, and supportive policies.

Objectives

Research & Development – Promote scientific studies on the efficacy, safety, and potential applications of medical cannabis.
Policy Advocacy – Support evidence-based policies and regulations to enhance patient access and industry standards.
Education & Awareness – Provide reliable information to healthcare professionals, patients, and the public on medical cannabis benefits and responsible use.
Quality & Safety Standards – Establish and uphold guidelines for cultivation, processing, and distribution to ensure product consistency and safety.
Patient Access & Support – Advocate for fair access to medical cannabis and develop resources for patients and caregivers.
Industry Collaboration – Facilitate partnerships between researchers, medical professionals, businesses, and regulators to drive innovation and compliance.

Rationale

The establishment of a Cannabis Medicine Advisory Panel is essential to address the growing demand for safe, effective, and well-regulated medical cannabis treatments. As scientific research continues to demonstrate the therapeutic potential of cannabis, there remains a critical need to bridge the gap between policy, medical practice, and industry standards.

Key reasons for forming this working group include:

Bridging Science and Policy – There is a disconnect between emerging research on cannabis-based medicine and current regulations. The group aims to facilitate evidence-based policymaking.
Ensuring Patient Safety – Standardized guidelines are necessary to ensure product quality, dosage accuracy, and responsible use to protect patients.
Expanding Medical Knowledge – Healthcare providers need access to accurate, research-backed information to confidently prescribe or recommend medical cannabis.
Promoting Ethical Industry Growth – With the rapid expansion of the cannabis industry, ethical and regulatory frameworks must be established to prevent misinformation and malpractice.
Advocating for Patient Access – Many patients face legal and logistical barriers to obtaining medical cannabis. The group will work towards policies that improve accessibility.
Encouraging Interdisciplinary Collaboration – Bringing together researchers, clinicians, policymakers, and industry leaders ensures a holistic approach to medical cannabis regulation and application.

If you are interested in joining the Cannabis Medicine Advisory Panel as a corporate partner, please contact Ravin Persaud (CEO) for more details.

Collaborations

We are working together with a trusted group of Contract Research Organisations and have established partnerships with the leading academic institutions in the UK as well as a range of external experts globally.

What we offer

Project Management

Scoping Reviews
Project Coordination
Scientific Due Diligence
Grant Writing

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Conducting Research

Qualitative Research
Cross Sectional and Longitudinal Surveys
Real World Evidence Collection and Analysis
Statistical Analysis

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Clinical Trial Development

Literature Reviews
Protocol Development for Clinical Trials
Clinical Trial Project Management
Navigating Regulatory Process

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Communications and Marketing

Scientific writing
Communication of results
Materials and Assets Design
Event Curation

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.